ArticleHeliyon2020
HMGB1 as a potential biomarker and therapeutic target for severe COVID-19.
Ruochan Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
106 papers cite itlatest 60 shown
this paperpooled ittrialcites it
ArticleHeliyon2020
Ruochan Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.